1 Market Overview of Neuromodulation 1.1 Neuromodulation Market Overview 1.1.1 Neuromodulation Product Scope 1.1.2 Neuromodulation Market Status and Outlook 1.2 Global Neuromodulation Market Size Overview by Region 2016 VS 2021VS 2027 1.3 Global Neuromodulation Market Size by Region (2016-2027) 1.4 Global Neuromodulation Historic Market Size by Region (2016-2021) 1.5 Global Neuromodulation Market Size Forecast by Region (2022-2027) 1.6 Key Regions, Neuromodulation Market Size (2016-2027) 1.6.1 North America Neuromodulation Market Size (2016-2027) 1.6.2 Europe Neuromodulation Market Size (2016-2027) 1.6.3 Asia-Pacific Neuromodulation Market Size (2016-2027) 1.6.4 Latin America Neuromodulation Market Size (2016-2027) 1.6.5 Middle East & Africa Neuromodulation Market Size (2016-2027) 2 Neuromodulation Market Overview by Type 2.1 Global Neuromodulation Market Size by Type: 2016 VS 2021 VS 2027 2.2 Global Neuromodulation Historic Market Size by Type (2016-2021) 2.3 Global Neuromodulation Forecasted Market Size by Type (2022-2027) 2.4 Internal Treatment 2.5 External Treatment 3 Neuromodulation Market Overview by Application 3.1 Global Neuromodulation Market Size by Application: 2016 VS 2021 VS 2027 3.2 Global Neuromodulation Historic Market Size by Application (2016-2021) 3.3 Global Neuromodulation Forecasted Market Size by Application (2022-2027) 3.4 Ischemia 3.5 Chronic Pain 3.6 Parkinson’s 3.7 Depression 3.8 Tremor 3.9 Epilepsy 3.10 Migraine 4 Neuromodulation Competition Analysis by Players 4.1 Global Neuromodulation Market Size by Players (2016-2021) 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation as of 2020) 4.3 Date of Key Players Enter into Neuromodulation Market 4.4 Global Top Players Neuromodulation Headquarters and Area Served 4.5 Key Players Neuromodulation Product Solution and Service 4.6 Competitive Status 4.6.1 Neuromodulation Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 Medtronic 5.1.1 Medtronic Profile 5.1.2 Medtronic Main Business 5.1.3 Medtronic Neuromodulation Products, Services and Solutions 5.1.4 Medtronic Neuromodulation Revenue (US$ Million) & (2016-2021) 5.1.5 Medtronic Recent Developments 5.2 Boston Scientific Corporation 5.2.1 Boston Scientific Corporation Profile 5.2.2 Boston Scientific Corporation Main Business 5.2.3 Boston Scientific Corporation Neuromodulation Products, Services and Solutions 5.2.4 Boston Scientific Corporation Neuromodulation Revenue (US$ Million) & (2016-2021) 5.2.5 Boston Scientific Corporation Recent Developments 5.3 Abbott 5.5.1 Abbott Profile 5.3.2 Abbott Main Business 5.3.3 Abbott Neuromodulation Products, Services and Solutions 5.3.4 Abbott Neuromodulation Revenue (US$ Million) & (2016-2021) 5.3.5 LivaNova Recent Developments 5.4 LivaNova 5.4.1 LivaNova Profile 5.4.2 LivaNova Main Business 5.4.3 LivaNova Neuromodulation Products, Services and Solutions 5.4.4 LivaNova Neuromodulation Revenue (US$ Million) & (2016-2021) 5.4.5 LivaNova Recent Developments 5.5 Synapse Biomedical, Inc. 5.5.1 Synapse Biomedical, Inc. Profile 5.5.2 Synapse Biomedical, Inc. Main Business 5.5.3 Synapse Biomedical, Inc. Neuromodulation Products, Services and Solutions 5.5.4 Synapse Biomedical, Inc. Neuromodulation Revenue (US$ Million) & (2016-2021) 5.5.5 Synapse Biomedical, Inc. Recent Developments 5.6 Nevro Corporation 5.6.1 Nevro Corporation Profile 5.6.2 Nevro Corporation Main Business 5.6.3 Nevro Corporation Neuromodulation Products, Services and Solutions 5.6.4 Nevro Corporation Neuromodulation Revenue (US$ Million) & (2016-2021) 5.6.5 Nevro Corporation Recent Developments 5.7 NeuroSigma 5.7.1 NeuroSigma Profile 5.7.2 NeuroSigma Main Business 5.7.3 NeuroSigma Neuromodulation Products, Services and Solutions 5.7.4 NeuroSigma Neuromodulation Revenue (US$ Million) & (2016-2021) 5.7.5 NeuroSigma Recent Developments 5.8 NeuroPace 5.8.1 NeuroPace Profile 5.8.2 NeuroPace Main Business 5.8.3 NeuroPace Neuromodulation Products, Services and Solutions 5.8.4 NeuroPace Neuromodulation Revenue (US$ Million) & (2016-2021) 5.8.5 NeuroPace Recent Developments 5.9 Neuronetics 5.9.1 Neuronetics Profile 5.9.2 Neuronetics Main Business 5.9.3 Neuronetics Neuromodulation Products, Services and Solutions 5.9.4 Neuronetics Neuromodulation Revenue (US$ Million) & (2016-2021) 5.9.5 Neuronetics Recent Developments 5.10 BioControl Medical 5.10.1 BioControl Medical Profile 5.10.2 BioControl Medical Main Business 5.10.3 BioControl Medical Neuromodulation Products, Services and Solutions 5.10.4 BioControl Medical Neuromodulation Revenue (US$ Million) & (2016-2021) 5.10.5 BioControl Medical Recent Developments 6 North America 6.1 North America Neuromodulation Market Size by Country (2016-2027) 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Neuromodulation Market Size by Country (2016-2027) 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Neuromodulation Market Size by Region (2016-2027) 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Neuromodulation Market Size by Country (2016-2027) 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Neuromodulation Market Size by Country (2016-2027) 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Neuromodulation Market Dynamics 11.1 Neuromodulation Industry Trends 11.2 Neuromodulation Market Drivers 11.3 Neuromodulation Market Challenges 11.4 Neuromodulation Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Neuromodulation Market Size (US$ Million) Comparison by Region 2016 VS 2021 VS 2027 Table 2. Global Neuromodulation Market Size by Region (2016-2021) & (US$ Million) Table 3. Global Neuromodulation Market Size Share by Region (2016-2021) Table 4. Global Neuromodulation Forecasted Market Size by Region (2022-2027) & (US$ Million) Table 5. Global Neuromodulation Forecasted Market Size Share by Region (2022-2027) Table 6. Global Neuromodulation Market Size (US$ Million) by Type: 2016 VS 2021 VS 2027 Table 7. Global Neuromodulation Market Size by Type (2016-2021) & (US$ Million) Table 8. Global Neuromodulation Revenue Market Share by Type (2016-2021) Table 9. Global Neuromodulation Forecasted Market Size by Type (2022-2027) & (US$ Million) Table 10. Global Neuromodulation Revenue Market Share by Type (2022-2027) Table 11. Global Neuromodulation Market Size (US$ Million) by Application: 2016 VS 2021 VS 2027 Table 12. Global Neuromodulation Market Size by Application (2016-2021) & (US$ Million) Table 13. Global Neuromodulation Revenue Market Share by Application (2016-2021) Table 14. Global Neuromodulation Forecasted Market Size by Application (2022-2027) & (US$ Million) Table 15. Global Neuromodulation Revenue Market Share by Application (2022-2027) Table 16. Global Neuromodulation Revenue (US$ Million) by Players (2016-2021) Table 17. Global Neuromodulation Revenue Market Share by Players (2016-2021) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neuromodulation as of 2020) Table 19. Date of Key Manufacturers Enter into Neuromodulation Market Table 20. Global Neuromodulation Top Players Headquarters and Area Served Table 21. Neuromodulation Product Solution and Service Table 22. Global Neuromodulation Players Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Medtronic Basic Information List Table 25. Medtronic Description and Business Overview Table 26. Medtronic Neuromodulation Products, Services and Solutions Table 27. Revenue (US$ Million) in Neuromodulation Business of Medtronic (2016-2021) Table 28. Medtronic Recent Developments Table 29. Boston Scientific Corporation Basic Information List Table 30. Boston Scientific Corporation Description and Business Overview Table 31. Boston Scientific Corporation Neuromodulation Products, Services and Solutions Table 32. Revenue (US$ Million) in Neuromodulation Business of Boston Scientific Corporation (2016-2021) Table 33. Boston Scientific Corporation Recent Developments Table 34. Abbott Basic Information List Table 35. Abbott Description and Business Overview Table 36. Abbott Neuromodulation Products, Services and Solutions Table 37. Revenue (US$ Million) in Neuromodulation Business of Abbott (2016-2021) Table 38. Abbott Recent Developments Table 39. LivaNova Basic Information List Table 40. LivaNova Description and Business Overview Table 41. LivaNova Neuromodulation Products, Services and Solutions Table 42. Revenue (US$ Million) in Neuromodulation Business of LivaNova (2016-2021) Table 43. LivaNova Recent Developments Table 44. Synapse Biomedical, Inc. Basic Information List Table 45. Synapse Biomedical, Inc. Description and Business Overview Table 46. Synapse Biomedical, Inc. Neuromodulation Products, Services and Solutions Table 47. Revenue (US$ Million) in Neuromodulation Business of Synapse Biomedical, Inc. (2016-2021) Table 48. Synapse Biomedical, Inc. Recent Developments Table 49. Nevro Corporation Basic Information List Table 50. Nevro Corporation Description and Business Overview Table 51. Nevro Corporation Neuromodulation Products, Services and Solutions Table 52. Revenue (US$ Million) in Neuromodulation Business of Nevro Corporation (2016-2021) Table 53. Nevro Corporation Recent Developments Table 54. NeuroSigma Basic Information List Table 55. NeuroSigma Description and Business Overview Table 56. NeuroSigma Neuromodulation Products, Services and Solutions Table 57. Revenue (US$ Million) in Neuromodulation Business of NeuroSigma (2016-2021) Table 58. NeuroSigma Recent Developments Table 59. NeuroPace Basic Information List Table 60. NeuroPace Description and Business Overview Table 61. NeuroPace Neuromodulation Products, Services and Solutions Table 62. Revenue (US$ Million) in Neuromodulation Business of NeuroPace (2016-2021) Table 63. NeuroPace Recent Developments Table 64. Neuronetics Basic Information List Table 65. Neuronetics Description and Business Overview Table 66. Neuronetics Neuromodulation Products, Services and Solutions Table 67. Revenue (US$ Million) in Neuromodulation Business of Neuronetics (2016-2021) Table 68. Neuronetics Recent Developments Table 69. BioControl Medical Basic Information List Table 70. BioControl Medical Description and Business Overview Table 71. BioControl Medical Neuromodulation Products, Services and Solutions Table 72. Revenue (US$ Million) in Neuromodulation Business of BioControl Medical (2016-2021) Table 73. BioControl Medical Recent Developments Table 74. North America Neuromodulation Market Size by Country (2016-2021) & (US$ Million) Table 75. North America Neuromodulation Market Size by Country (2022-2027) & (US$ Million) Table 76. Europe Neuromodulation Market Size by Country (2016-2021) & (US$ Million) Table 77. Europe Neuromodulation Market Size by Country (2022-2027) & (US$ Million) Table 78. Asia-Pacific Neuromodulation Market Size by Region (2016-2021) & (US$ Million) Table 79. Asia-Pacific Neuromodulation Market Size by Region (2022-2027) & (US$ Million) Table 80. Asia-Pacific Neuromodulation Market Share by Region (2016-2021) Table 81. Asia-Pacific Neuromodulation Market Share by Region (2022-2027) Table 82. Latin America Neuromodulation Market Size by Country (2016-2021) & (US$ Million) Table 83. Latin America Neuromodulation Market Size by Country (2022-2027) & (US$ Million) Table 84. Middle East & Africa Neuromodulation Market Size by Players (2016-2021) & (US$ Million) Table 85. Middle East & Africa Neuromodulation Market Size by Country (2022-2027) & (US$ Million) Table 86. Neuromodulation Market Trends Table 87. Neuromodulation Market Drivers Table 88. Neuromodulation Market Challenges Table 89. Neuromodulation Market Restraints Table 90. Research Programs/Design for This Report Table 91. Key Data Information from Secondary Sources Table 92. Key Data Information from Primary Sources List of Figures Figure 1. Global Neuromodulation Market Size Year-over-Year 2016-2027 & (US$ Million) Figure 2. Global Neuromodulation Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 3. Global Neuromodulation Market Share by Regions: 2021 VS 2027 Figure 4. Global Neuromodulation Forecasted Market Size Share by Region (2022-2027) Figure 5. North America Neuromodulation Market Size (US$ Million) Growth Rate (2016-2027) Figure 6. Europe Neuromodulation Market Size (US$ Million) and Growth Rate (2016-2027) Figure 7. Asia-Pacific Neuromodulation Market Size (US$ Million) and Growth Rate (2016-2027) Figure 8. Latin America Neuromodulation Market Size (US$ Million) and Growth Rate (2016-2027) Figure 9. Middle East & Africa Neuromodulation Market Size (US$ Million) and Growth Rate (2016-2027) Figure 10. Global Neuromodulation Market Size Share by Type in 2021 & 2027 Figure 11. Internal Treatment Market Size (US$ Million) YoY Growth (2016-2027) Figure 12. External Treatment Market Size (US$ Million) YoY Growth (2016-2027) Figure 13. Global Neuromodulation Market Size Share by Application in 2021 & 2027 Figure 14. Ischemia Market Size (US$ Million) YoY Growth (2016-2027) Figure 15. Chronic Pain Market Size (US$ Million) YoY Growth (2016-2027) Figure 16. Parkinson’s Market Size (US$ Million) YoY Growth (2016-2027) Figure 17. Depression Market Size (US$ Million) YoY Growth (2016-2027) Figure 18. Tremor Market Size (US$ Million) YoY Growth (2016-2027) Figure 19. Epilepsy Market Size (US$ Million) YoY Growth (2016-2027) Figure 20. Neuromodulation Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 21. Global Top 5 and Top 10 Players Neuromodulation Market Share in 2020 Figure 22. North America Neuromodulation Market Share by Country (2016-2027) Figure 23. United States Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 24. Canada Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 25. Germany Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 26. France Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 27. U.K. Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 28. Italy Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 29. Russia Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 30. Nordic Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 31. Rest of Europe Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 32. Asia-Pacific Neuromodulation Market Share by Region (2016-2027) Figure 33. China Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 34. Japan Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 35. South Korea Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 36. Southeast Asia Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 37. India Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 38. Australia Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 39. Rest of Asia-Pacific Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 40. Latin America Neuromodulation Market Share by Country (2016-2027) Figure 41. Mexico Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 42. Brazil Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 43. Rest of Latin America Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 44. Middle East & Africa Neuromodulation Market Share by Country (2016-2027) Figure 45. Turkey Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 46. Saudi Arabia Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 47. UAE Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 48. Rest of Middle East & Africa Neuromodulation Market Size (2016-2027) & (US$ Million) Figure 49. Bottom-up and Top-down Approaches for This Report Figure 50. Data Triangulation

Medtronic Boston Scientific Corporation Abbott LivaNova Synapse Biomedical, Inc. Nevro Corporation NeuroSigma NeuroPace Neuronetics BioControl Medical